On Friday, the Food and Drug Administration declared the semaglutide shortage over, sending Hims & Hers shares down 26%.
Thank you for joining us following the release of Stanmore's 2024 full year results earlier today. To begin, 2024 has been another remarkable year for Stanmore, as summarized by the highlights on ...
Oracle's currency headwinds in 3Q are expected to alleviate due to the weak dollar over the past few weeks. Check out why I ...
Even before Friday’s slide jolted the US stock market out of its calm, some traders were preparing for unrest.
Oil stocks can be excellent sources of passive income for investors who can stomach the volatility of the cyclical energy ...
Nvidia’s earnings caps off a Magnificent 7 earnings season that has seen some big tech stocks suffer in the light of DeepSeek ...
Franklin, Tenn.-based CHS operated 76 hospitals as of Dec. 31, down from 78 on the same date in 2023, according to a Feb. 19 regulatory filing. In February 2024, the system announced a $1 billion ...
WeightWatchers will host a conference call at 5:00 p.m. ET the same day. During the conference call, Tara Comonte, Interim President and Chief Executive Officer, and Felicia DellaFortuna, Chief ...
Domino's Pizza on Monday missed estimates for quarterly same-store sales and said the consumer environment for fast food ...
The sector had an upbeat earnings season. But continued weakness in China and U.S. tariffs could leave even the most ...
The bullish call now comes at a time when the benchmark index has fallen about 14% from its September peak as foreigners net ...
Orano saw "exceptional" financial results in 2024, CEO Nicolas Maes told investors - and positive trends are set to continue ...